AABB is accepting questions for the "Ask the FDA & CMS/CLIA" session at the 2017 AABB Annual Meeting, to be held Oct. 7-10 in San Diego. This popular session provides an opportunity for FDA representatives to respond to member questions and present the agency's current thinking on policies, regulations, guidance documents and inspection programs relevant to the oversight of blood and cellular therapies. All questions must be submitted to email@example.com by Friday, Aug. 25.
AABB accepting questions for "Ask the FDA & CMS/CLIA" session at the AABB Annual Meeting
Sign up for AABB SmartBrief
News about transfusion and cellular therapies
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.